Cytek Biosciences, Inc. (CTKB)

About Cytek Biosciences, Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

As of November 3, 2026, Cytek Biosciences, Inc. (CTKB) stock climbed to $6.04, up 4.59% (+$0.27) versus the previous close. On the day, shares have traded between $5.77 and $6.09. That puts CTKB near the top of its 52-week range of $3.31 to $6.33. Cytek Biosciences, Inc. operates in the laboratory analytical instruments space and carries a market capitalization of roughly $796.80 million, with about 365.4K shares changing hands.

Latest CTKB news

• Cytek Biosciences to Participate in Upcoming Investor ConferencesYahoo Finance· Oct 29, 4:30 PM ET
• Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseYahoo Finance· Oct 29, 9:00 AM ETNVAX
• Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out forYahoo Finance· Oct 28, 9:00 AM ET
• Cytek Biosciences (CTKB) Stock Sees Modest Fair Value Lift As Analysts Weigh ProfitabilityYahoo Finance· Oct 24, 8:14 PM ET
• Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026Yahoo Finance· Oct 21, 4:05 PM ET
• Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining ProfitabilityYahoo Finance· Sep 29, 10:14 AM ET
• Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis ToolYahoo Finance· Sep 23, 5:00 PM ET
• Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock?Yahoo Finance· Sep 17, 8:48 AM ET

Source: Yahoo Finance RSS · Updated November 3, 2026

Want CTKB headlines, alerts and AI research in one place? Create a free account →

• $CTKB Cytek Biosciences options open interest rises in focus this week https://www.macroaxis.com/stock-options/CTKB/Cytek-Biosciences?utm_source=dlvr.it&utm_medium=stocktwits

  @macroaxis· Oct 2, 8:15 PM ET

• 14 #stockbreakouts $CTKB, $EMCS, $PGRO, $PS, $RSKD, $VKTX (gap). Two sub-$1, one $1-2.

  @fallondpicks· Sep 22, 6:26 PM ET

• $CTKB let’s bang bro. ONTA 🐒🍌🧠⏰♾️

  @Doozio· Sep 17, 7:52 PM ET· Bullish

• https://www.marketbeat.com/earnings/reports/2026-8-5-cytek-biosciences-inc-stock/ $CTKB Cytek Biosciences Earnings Transcript

  @EarningsInsider· Aug 5, 5:31 PM ET

• $CTKB Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.09 down -125.00% YoY • Reported revenue of $48.14M up 5.57% YoY • Cytek Biosciences is updating its revenue outlook for the full year 2026 to be in the range of $207 million to $212 million, raising the m…

  @StocktwitsEarnings· Aug 5, 4:29 PM ET

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →